COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

22/12/2017 - 18:15

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Cannabis Wheaton Income Corp. Announces Signing of Definitive Agreement With Streaming Partner CannTx Life Sciences Inc.

22/12/2017 - 18:00

VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that further to its [...]

Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch

22/12/2017 - 17:57

REDWOOD CITY, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

Cannabis Wheaton Income Corp. Announces Private Placement of Convertible Debenture Units and Conversion of Prior Convertible Debenture Units

22/12/2017 - 16:04

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

American Health Council Appoints Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC to its Nursing Board

22/12/2017 - 15:46

NEW YORK, Dec. 22, 2017 (GLOBE NEWSWIRE) -- The American Health Council Board of Nurses welcomes Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC as an affiliate. With an extensive 38 years within the healthcare industry, [...]

BioCorRx Recovery Program Used in Lieu of Conviction in Ohio

22/12/2017 - 15:41

ANAHEIM, CA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that that [...]

Canada House Wellness Group’s Intended Uses of Funds from Recently Closed $8.6 Million Convertible Debenture Unit Financing

22/12/2017 - 15:39

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

Imaging3’s New CEO Provides end-of-year Company Update

22/12/2017 - 15:30

BURBANK, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry, is finishing a transformative 2017 year and [...]

Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 36th Annual Healthcare Conference on January 10, 2018

22/12/2017 - 15:05

BOSTON, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will [...]

Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Share Repurchase Program

22/12/2017 - 15:00

NOGALES, Ariz., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

GBT Appoints Wendy L. Yarno to Board of Directors

22/12/2017 - 15:00

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced the appointment of Wendy L. Yarno to the company’s board of directors. Ms. Yarno has [...]

Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics

22/12/2017 - 14:37

Company to focus on advancing the clinical development of ELX-02, a disease-modifying therapy for genetic diseases caused by nonsense mutations WALTHAM, Mass., REHOVOT, Israel, and SAN DIEGO, Dec. 22, 2017 (GLOBE [...]

Tauriga Sciences, Inc. Extinguishes its Largest Remaining Balance Sheet Liability for One Time Cash Payment of $15,000 and One Time Issuance of 5,000,000 Restricted Shares; Liability Dated Back to the Years 2010/2011 and Totaled $177,883.71

22/12/2017 - 14:30

NEW YORK, NY, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]

Achaogen Announces New Employment Inducement Grants

22/12/2017 - 14:01

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

Portola Pharmaceuticals to Webcast Corporate Update on January 9, 2018

22/12/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that it will host an investor event to discuss expected corporate and product milestones in [...]

Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of peripheral T-cell lymphoma (PTCL)

22/12/2017 - 14:00

La Chaux-de-Fonds, Switzerland, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the active moiety [...]

Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy

22/12/2017 - 13:30

PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ: AGRX ), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued a complete response [...]

RedHill Biopharma Announces Initiation of Phase IIa Study with ABC294640 (YELIVA®) for Cholangiocarcinoma at Mayo Clinic and MD Anderson

22/12/2017 - 13:00

YELIVA ® , a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the treatment of cholangiocarcinoma Cholangiocarcinoma (bile duct cancer) is a highly lethal malignancy for which there [...]

Avivagen Inc. Announces the Granting of Options

22/12/2017 - 12:30

OTTAWA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V: VIV ) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]